Form 4: Health Catalyst CEO Executes Sell-to-Cover Transaction

CEO Benjamin Albert disposed of 336 shares of Health Catalyst, Inc. to satisfy tax withholding obligations.

Summary

• CEO Benjamin Albert sold 336 shares of Health Catalyst, Inc. (HCAT) common stock on June 1, 2026.
• The transaction was executed at a price of $1.3702 per share.
• The sale was a mandatory 'sell-to-cover' transaction to satisfy tax withholding obligations related to the vesting of Restricted Stock Units (RSUs).
• Following this transaction, the CEO maintains a beneficial ownership of 1,458,456 shares.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as it is a routine administrative action required by tax law and company policy rather than a discretionary market move.

Positives

• The transaction was non-discretionary and mandated by the company's equity incentive plan requirements.

Negatives

• The transaction reflects a reduction in the CEO's direct shareholding, albeit for tax purposes.

Risks

• None identified; this is a routine administrative tax-related transaction.

Future Outlook

No forward-looking guidance provided in this filing.

Industry Context

StockSavvy.ai notes that sell-to-cover transactions are standard corporate governance practices for executives to manage tax liabilities associated with equity compensation and do not typically signal a change in management sentiment regarding company performance.

Comparison to Industry Standards

• The transaction follows standard industry practice for executive compensation tax compliance.
• The use of mandatory sell-to-cover plans is consistent with governance policies at other publicly traded healthcare technology firms.

Stakeholder Impact

• Minimal impact on shareholders as the transaction was non-discretionary and small in volume relative to total holdings.

Key Dates

Keywords

Health Catalyst, HCAT, Insider Trading, Form 4, CEO, Equity Incentive Plan